|
|
在研机构- |
|
在研适应症- |
|
最高研发阶段终止 |
首次获批国家/地区- |
首次获批日期- |
Efficacy and Safety of Ivermectin Versus Albendazole for Chronic Strongyloidiasis
A prospective controlled trial to compare the efficacy and safety of 7-day albendazole, single dose ivermectin, and 2-single dose ivermectin in 72 patients with chronic strongyloidiasis will be conducted at Siriraj Hospital, Bangkok, Thailand.
100 项与 Atlantic Laboratories Corp. Ltd. 相关的临床结果
0 项与 Atlantic Laboratories Corp. Ltd. 相关的专利(医药)
100 项与 Atlantic Laboratories Corp. Ltd. 相关的药物交易
100 项与 Atlantic Laboratories Corp. Ltd. 相关的转化医学